Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1038 participants.

Also called NCT04057300

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 1,038 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04057300
Other papers using this trial's data
  • Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes trial (TC4): a Bayesian pragmatic cluster randomized controlled trial CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2025-03-30 DOI, PubMed 40164463, PMC11957720 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04057300. Randomized; no masking; primary purpose treatment. Start 2018-10-01 (actual); primary completion 2022-04-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes
Acronym
TC4
Condition
Acute Coronary Syndrome
Intervention (Drug)
Ticagrelor 90mg
Intervention (Drug)
Clopidogrel 75mg
Intervention (Drug)
acetylsalicylic acid (ASA) 81mg
Lead sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre (class: other)
Collaborator
Canadian Institutes of Health Research (CIHR) (class: other government)

Record details

Record id
cardio:ct-nct04057300
Content hash
f9892c990ac21a4da50829875598a158cbb5ce039e909dbeab5c5ba140b67d47